Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 1422 | 2572 | 38.5 | 74% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | RELAXIVITY | Author keyword | 104 | 51% | 6% | 145 |
| 2 | MRI CONTRAST AGENTS | Author keyword | 52 | 48% | 3% | 80 |
| 3 | GADOLINIUM COMPLEXES | Author keyword | 34 | 59% | 1% | 38 |
| 4 | DIAGNOST RADIOL MOL MED | Address | 31 | 92% | 0% | 12 |
| 5 | GEN ORGAN BIOMED CHEM | Address | 21 | 33% | 2% | 53 |
| 6 | GDIII COMPLEXES | Author keyword | 21 | 78% | 1% | 14 |
| 7 | MRI CONTRAST AGENT | Author keyword | 21 | 33% | 2% | 52 |
| 8 | CONTRAST AGENTS | Author keyword | 18 | 11% | 6% | 152 |
| 9 | IMAGING AGENTS | Author keyword | 15 | 15% | 4% | 95 |
| 10 | UNIV KARLOVA | Address | 12 | 75% | 0% | 9 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | RELAXIVITY | 104 | 51% | 6% | 145 | Search RELAXIVITY | Search RELAXIVITY |
| 2 | MRI CONTRAST AGENTS | 52 | 48% | 3% | 80 | Search MRI+CONTRAST+AGENTS | Search MRI+CONTRAST+AGENTS |
| 3 | GADOLINIUM COMPLEXES | 34 | 59% | 1% | 38 | Search GADOLINIUM+COMPLEXES | Search GADOLINIUM+COMPLEXES |
| 4 | GDIII COMPLEXES | 21 | 78% | 1% | 14 | Search GDIII+COMPLEXES | Search GDIII+COMPLEXES |
| 5 | MRI CONTRAST AGENT | 21 | 33% | 2% | 52 | Search MRI+CONTRAST+AGENT | Search MRI+CONTRAST+AGENT |
| 6 | CONTRAST AGENTS | 18 | 11% | 6% | 152 | Search CONTRAST+AGENTS | Search CONTRAST+AGENTS |
| 7 | IMAGING AGENTS | 15 | 15% | 4% | 95 | Search IMAGING+AGENTS | Search IMAGING+AGENTS |
| 8 | DTPA DERIVATIVE | 12 | 86% | 0% | 6 | Search DTPA+DERIVATIVE | Search DTPA+DERIVATIVE |
| 9 | GADOLINIUM COMPLEX | 11 | 47% | 1% | 17 | Search GADOLINIUM+COMPLEX | Search GADOLINIUM+COMPLEX |
| 10 | DTPA BISAMIDE | 8 | 100% | 0% | 5 | Search DTPA+BISAMIDE | Search DTPA+BISAMIDE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MRI CONTRAST AGENTS | 170 | 31% | 18% | 455 |
| 2 | HIGH RELAXIVITY | 149 | 69% | 5% | 129 |
| 3 | RELAXIVITY | 124 | 42% | 9% | 228 |
| 4 | GADOLINIUMIII COMPLEXES | 107 | 63% | 4% | 106 |
| 5 | WATER EXCHANGE RATE | 104 | 90% | 2% | 45 |
| 6 | GDIII COMPLEXES | 86 | 71% | 3% | 69 |
| 7 | FAST WATER EXCHANGE | 79 | 85% | 2% | 41 |
| 8 | GADOLINIUM COMPLEXES | 73 | 61% | 3% | 77 |
| 9 | SPHERE WATER MOLECULES | 72 | 91% | 1% | 30 |
| 10 | LANTHANIDEIII COMPLEXES | 64 | 35% | 6% | 148 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CONTRAST MEDIA & MOLECULAR IMAGING | 5 | 12% | 2% | 44 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications | 1999 | 2391 | 296 | 72% |
| Lanthanide Probes for Bioresponsive Imaging | 2014 | 59 | 292 | 42% |
| Strategies for increasing the sensitivity of gadolinium based MRI contrast agents | 2006 | 546 | 32 | 63% |
| Lanthanide(III) chelates for NMR biomedical applications | 1998 | 457 | 29 | 86% |
| Recent advances in Gd-chelate based bimodal optical/MRI contrast agents | 2015 | 2 | 61 | 61% |
| Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes | 2008 | 178 | 236 | 83% |
| Gadolinium-based contrast agents for magnetic resonance cancer imaging | 2013 | 30 | 89 | 69% |
| Protein-Targeted Gadolinium-Based Magnetic Resonance Imaging (MRI) Contrast Agents: Design and Mechanism of Action | 2009 | 170 | 39 | 79% |
| Using lanthanide ions in molecular bioimaging | 2015 | 2 | 79 | 42% |
| High-Relaxivity MRI Contrast Agents: Where Coordination Chemistry Meets Medical Imaging | 2008 | 162 | 83 | 67% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | DIAGNOST RADIOL MOL MED | 31 | 92% | 0.5% | 12 |
| 2 | GEN ORGAN BIOMED CHEM | 21 | 33% | 2.1% | 53 |
| 3 | UNIV KARLOVA | 12 | 75% | 0.3% | 9 |
| 4 | NMR MOL IMAGING | 11 | 30% | 1.2% | 31 |
| 5 | CHIM INORGAN BIOINORGAN | 10 | 23% | 1.4% | 37 |
| 6 | DIPARTIMENTO SCI AMBIENTE VITA | 9 | 18% | 1.7% | 45 |
| 7 | DIAGNOST INTERVENT IMAGIOL | 8 | 70% | 0.3% | 7 |
| 8 | ROGERS MAGNET ONANCE | 8 | 46% | 0.5% | 13 |
| 9 | ORGAN BIOMED CHEM | 8 | 56% | 0.4% | 10 |
| 10 | EPFL BCH | 6 | 39% | 0.5% | 12 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000206103 | MOL MED MED BIOL ENGN//WATER PROTON RELAXIVITY//MOL SUR E PHYS NANOSCI |
| 2 | 0.0000148600 | PARAMAGNETIC NMR RELAXATION//CHEM BIOL COMPUTAT CHEM//DSM RECONNAISSANCE ION |
| 3 | 0.0000141942 | GE 68 GA 68 GENERATOR//GALLIUM 68//GA 68 |
| 4 | 0.0000101941 | NEPHROGENIC SYSTEMIC FIBROSIS//NEPHROGENIC FIBROSING DERMOPATHY//GADOLINIUM |
| 5 | 0.0000097679 | MAGNETIZATION TRANSFER//CEST//CHEMICAL EXCHANGE SATURATION TRANSFER |
| 6 | 0.0000093549 | MOTEXAFIN GADOLINIUM//XCYTRIN//TEXAPHYRINS |
| 7 | 0.0000083610 | LANTHANIDE SUPRAMOL CHEM//SPARKLE MODEL//WCU NEXT GENERAT PHOTOVOLTA SYST |
| 8 | 0.0000081002 | F 19 MRI//FLUORINE STUDIES//19F MRI |
| 9 | 0.0000080525 | AV NIKOLAEVS INORGAN CHEM//GAS PHASE ACETOXYLATION//COMPLEXES OF LANTHANIDES |
| 10 | 0.0000073402 | TETRAAZA MACROCYCLE//FUNCTIONAL PENDANT ARMS//OCTAAZAMACROCYCLE |